IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Via Adamello 16, 20139 Milan, Italy.
IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Via Adamello 16, 20139 Milan, Italy; Dipartimento di Oncologia Sperimentale, Istituto Europeo di Oncologia, 20141 Milan, Italy.
Dev Cell. 2014 Sep 8;30(5):553-68. doi: 10.1016/j.devcel.2014.08.006.
The role of endocytic proteins and the molecular mechanisms underlying epithelial cell cohesion and tumor dissemination are not well understood. Here, we report that the endocytic F-BAR-containing CDC42-interacting protein 4 (CIP4) is required for ERBB2- and TGF-β1-induced cell scattering, breast cancer (BC) cell motility and invasion into 3D matrices, and conversion from ductal breast carcinoma in situ to invasive carcinoma in mouse xenograft models. CIP4 promotes the formation of an E-cadherin-CIP4-SRC complex that controls SRC activation, E-cadherin endocytosis, and localized phosphorylation of the myosin light chain kinase, thereby impinging on the actomyosin contractility required to generate tangential forces to break cell-cell junctions. CIP4 is upregulated in ERBB2-positive human BC, correlates with increased distant metastasis, and is an independent predictor of poor disease outcome in subsets of BC patients. Thus, it critically controls cell-cell cohesion and is required for the acquisition of an invasive phenotype in breast tumors.
细胞内吞蛋白的作用及其在细胞间黏附和肿瘤扩散中的分子机制尚不清楚。本研究报道,含 F-BAR 的细胞内吞蛋白 CDC42 相互作用蛋白 4(CIP4)对于 ERBB2 和 TGF-β1 诱导的细胞分散、乳腺癌(BC)细胞运动和侵袭三维基质,以及从原位导管乳腺癌向小鼠异种移植模型中的浸润性乳腺癌的转化是必需的。CIP4 促进 E-钙黏蛋白-CIP4-SRC 复合物的形成,该复合物控制 SRC 的激活、E-钙黏蛋白的内吞作用以及肌球蛋白轻链激酶的局部磷酸化,从而影响产生切向力以破坏细胞-细胞连接所需的肌动球蛋白收缩力。CIP4 在 ERBB2 阳性的人 BC 中上调,与远处转移增加相关,并且是某些 BC 患者不良预后的独立预测因子。因此,它对细胞间黏附至关重要,并且是乳腺肿瘤获得浸润表型所必需的。